Remove 2023 Remove Diagnostic Imaging Remove Nuclear Medicine
article thumbnail

Bipartisan bill aims to boost Medicare patients’ access to diagnostic imaging agents

Radiology Business

The Facilitating Innovative Nuclear Diagnostics Act of 2023 would eliminate barriers to nuclear medicine, supporters charged.

article thumbnail

Helen Nadel, MD, FRCPC, on Imperatives for Nuclear Medicine and Molecular Imaging

Diagnostic Imaging

Nadel was announced as president of SNMMI for the 2023-2024 term at the 2023 SNMMI annual meeting taking place in Chicago.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Meet the Minnies 2024 finalists

AuntMinnie

An assistant professor of radiology and radiological science, Francis Deng, MD, is the Johns Hopkins radiology department's co-director of medical student diagnostic radiology electives. His area of expertise is neuroradiology, with a special emphasis on diagnostic imaging of the head, neck, brain, and spine. Elliot Fishman, MD.

article thumbnail

Mirion Medical Introduces Instadose VUE Dosimeter at Radiological Society of North America (RSNA) Annual Meeting

Imaging Technology

mtaschetta-millane Sat, 11/25/2023 - 06:00 November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry Services brand, at the 2023 Radiological Society of North America (RSNA) Meeting starting Sunday in Chicago, Illinois.

article thumbnail

The rise of theranostics: Part 5 -- Advice from center administrators

AuntMinnie

As nuclear medicine therapies gain stature compared to nuclear medicine in diagnostic imaging, hospital administrators may be eyeing the potential of adding theranostics services. Image courtesy of Washington University. "We This oversight has led to program launch setbacks, Beyder explained.

article thumbnail

Whole-body PET/CT Predicts Response to HER2-targeted Therapy in Metastatic Breast Cancer Patients

Imaging Technology

milla1cf Wed, 10/11/2023 - 13:08 October 11, 2023 — A new imaging agent, 68Ga-ABY-025 , can predict early metabolic response to human epidermal growth factor receptor 2 ( HER2 )-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in the September issue of The Journal of Nuclear Medicine.

article thumbnail

SNMMI Announces Julie Dawn Bolin, MS, CNMT, as President-Elect of the Technologist Section During 2023 Annual Meeting

Imaging Technology

The new slate of officers was introduced during the Society of Nuclear Medicine and Molecular Imaging’s 2023 Annual Meeting, held June 24-27. “I I and am very passionate about supporting the nuclear medicine technologist profession through advocacy and volunteerism.